Drug Type Small molecule drug |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Quercis Pharma AGStartup |
Active Organization- |
Inactive Organization Quercis Pharma AGStartup |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anemia, Sickle Cell | Phase 2 | CH | Quercis Pharma AGStartup | 18 Dec 2021 |
Hemorrhagic Fever, Ebola | Phase 2 | CH | Quercis Pharma AGStartup | 18 Dec 2021 |
Neoplasms | Phase 2 | CH | Quercis Pharma AGStartup | 18 Dec 2021 |
Venous Thromboembolism | Phase 2 | CH | Quercis Pharma AGStartup | 18 Dec 2021 |
Amyotrophic Lateral Sclerosis | Phase 1 | CH | Quercis Pharma AGStartup | 18 Dec 2021 |
COVID-19 | Phase 1 | CH | Quercis Pharma AGStartup | 18 Dec 2021 |